Dräger’s Atlan A350/A350XL Anesthesia Workstations Achieve U.S. DoD ATO Certification for Maximum Patient Data Security

12 August 2025 | Tuesday | News

Three-year certification under eMASS #4060 reinforces Dräger’s entire anesthesia portfolio as meeting the highest cybersecurity standards for medical devices in critical care settings.

Certification ensures highest level of patient data security a medical device can attain

Effective 7/14/2025 and expiring on 7/14/2028 under eMASS System ID #4060

Dräger, an international leader in medical and safety technologies, announced that the company's Atlan A350/A350 XL series of anesthesia workstations received Authority to Operate (ATO) certification under the Department of Defense's (DoD) Risk Management Framework (RMF) eMASS #4060.

 

"Cyberattacks continue to be a serious threat to hospitals – both clinically and financially," said President and CEO for Draeger, Inc., Lothar Thielen. "To help hospitals meet this challenge, Dräger embeds the latest cybersecurity technology deeply into our development processes. Our new Atlan anesthesia workstations now carry ATO certification, which is the highest level of security a medical device can hold."

 

Continuing a longstanding commitment to patient data security
Certification of Dräger's Atlan A350/A350XL anesthesia workstation follows the certifications of the Perseus A500 (eMASS # 2852) and Fabius MRI (eMASS # 2875) anesthesia workstations.  Now with the Atlan certification, Dräger anesthesia customers can have confidence knowing that Dräger's entire anesthesia machine portfolio has gone through this rigorous cyber-security review process.

Benefits of ATO-certified medical devices
Medical devices that have achieved an Authority to Operate (ATO) under the Risk Management Framework (RMF) offer significant advantages to hospitals, including:

  • Enhanced security: Rigorous security assessments ensure that these devices meet high standards for protecting sensitive patient data and maintaining the integrity of medical operations
  • Compliance assurance: Devices that comply with federal regulations and standards reduce the risk of legal and regulatory issues
  • Reliability and trust: Hospitals can trust that these devices have been thoroughly vetted for security and performance, leading to greater confidence in their use in critical environments
  • Interoperability: Devices with ATO are often designed to integrate seamlessly with other systems within the healthcare network, enhancing overall efficiency and effectiveness
  • Continuous monitoring: Ongoing monitoring and updates continually address new security threats, ensuring that devices remain secure over time
  • Faster installation: ATO-certified devices streamline the process of integrating device data with electronic medical records, centralized alarm stations, and remote notifications

These benefits enable ATO-certified medical devices to provide stronger patient data protection and carry a lower risk of cyberattacks.  

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close